XML 61 R60.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONCENTRATIONS (Details Textual) (USD $)
3 Months Ended 6 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Dec. 31, 2011
Jun. 30, 2012
Subsequent Event [Member]
Apr. 05, 2012
Subsequent Event [Member]
Jun. 30, 2012
Customer 1 [Member]
Jun. 30, 2011
Customer 1 [Member]
Jun. 30, 2012
Customer 1 [Member]
Jun. 30, 2011
Customer 1 [Member]
Jun. 30, 2012
Customer 2 [Member]
Jun. 30, 2011
Customer 2 [Member]
Jun. 30, 2012
Customer 3 [Member]
Jun. 30, 2011
Customer 3 [Member]
Jun. 30, 2012
Customer 4 [Member]
Jun. 30, 2011
Customer 4 [Member]
Entity Wide Revenue Major Customer Percentage               15.00% 15.00% 10.00% 13.00%            
Entity Wide Receivable Major Customer Percentage                   9.00% 12.00% 9.00% 10.00% 8.00% 10.00% 8.00% 9.00%
Net Revenue, Percentage 75.00% 82.00% 76.00% 80.00%                          
Common Stock, Shares, Issued (in shares) 4,570,000   4,570,000   4,560,000   5,000                    
Common Stock Issued, Fair Value (in dollars)             $ 12,000                    
Subsequent Event, Description     In July 2012, the Company received approved SFDA registration certificate for proprietary homecare medical CPAP product of Model DHR-CPAP-C5. The certificate is valid until July 1, 2016 and allows the Company to sell the products in mainland China.     The Company issued 5,000 shares to an investor relationship consultant on April 5, 2012 pursuant to a consulting agreement signed on January 9, 2012. The fair value of the shares granted on April 5, 2012 was approximately $12,000 based on the closing price on that date.On April 23, 2012, the Company signed a strategic cooperation agreement with Timesco of London Ltd., to be its exclusive distributor in mainland China for Timesco''''s entire laryngoscope Optima series of products in the next three years.